All Osiris Therapeutics articles
-
Blog
SEC charges Osiris Therapeutics with accounting fraud
The Securities and Exchange Commission this week charged biotech company Osiris Therapeutics and four former top executives with prioritizing revenue growth over lawful accounting and misleading investors in the process.